Josephine Harter Selected Research

tucotuzumab celmoleukin

1/2013	A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.
5/2004	Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josephine Harter Research Topics

Disease

5	Neoplasms (Cancer) 10/2020 - 05/2004
2	Adenocarcinoma 10/2012 - 09/2008
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Sepsis (Septicemia) 01/2018
1	Triple Negative Breast Neoplasms 01/2016
1	Hypophosphatemia 01/2013
1	Hypotension (Low Blood Pressure) 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2012
1	Leiomyosarcoma 07/2012
1	Choristoma (Ectopic Tissue) 09/2011
1	Goiter 12/2006
1	Thyroid Diseases (Thyroid Disease) 12/2006
1	Papillary Thyroid Cancer 06/2006
1	Ascites 05/2004
1	Ovarian Neoplasms (Ovarian Cancer) 05/2004
1	Ovarian Epithelial Carcinoma 05/2004

Drug/Important Bio-Agent (IBA)

2	Epithelial Cell Adhesion MoleculeIBA 01/2013 - 05/2004
2	tucotuzumab celmoleukinIBA 01/2013 - 05/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Estrogen Receptor betaIBA 01/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2016
1	Biological ProductsIBA 01/2013
1	CreatinineIBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	N-propionylprocainamideIBA 10/2012
1	Interleukin-2 (IL2)IBA 07/2012
1	Monoclonal AntibodiesIBA 07/2012
1	ChromiumIBA 05/2004
1	Therapeutic UsesIBA 05/2004

Therapy/Procedure

3	Therapeutics 10/2020 - 05/2004
2	Immunotherapy 07/2012 - 05/2004
2	Thyroidectomy 12/2006 - 06/2006
1	Cordotomy 09/2011
1	Laparotomy 09/2008
1	Cytoreduction Surgical Procedures 05/2004